PDS Biotechnology Corporation
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.37 |
11.25 |
23.15 |
3.80 |
106.75 |
| Przychód Δ r/r |
0.00% |
inf% |
2968.18% |
105.78% |
-83.59% |
2709.24% |
| Przychód (min) |
0.00 |
0.37 |
11.25 |
23.15 |
3.80 |
106.75 |
| Przychód (max) |
0.00 |
0.37 |
11.25 |
23.15 |
3.80 |
106.75 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-41.98 |
-32.44 |
-31.71 |
-32.26 |
-30.26 |
9.84 |
| Zysk netto % |
-inf% |
-8848.13% |
-281.90% |
-139.36% |
-796.21% |
9.22% |
| EPS (średnia) |
-1.11 |
-0.89 |
-0.86 |
-0.86 |
-0.83 |
0.27 |
| Liczba analityków (Przychody) |
0 |
2 |
2 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
3 |
3 |
3 |
3 |
1 |
1 |
| symbol |
PDSB |
PDSB |
PDSB |
PDSB |
PDSB |
PDSB |